Your browser doesn't support javascript.
loading
In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme.
Bhojnagarwala, Pratik S; O'Connell, Ryan P; Park, Daniel; Liaw, Kevin; Ali, Ali R; Bordoloi, Devivasha; Cassel, Joel; Tursi, Nicholas J; Gary, Ebony; Weiner, David B.
Affiliation
  • Bhojnagarwala PS; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
  • O'Connell RP; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
  • Park D; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
  • Liaw K; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
  • Ali AR; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
  • Bordoloi D; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
  • Cassel J; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
  • Tursi NJ; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
  • Gary E; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
  • Weiner DB; Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
Mol Ther Oncolytics ; 26: 289-301, 2022 Sep 15.
Article in En | MEDLINE | ID: mdl-36090479

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Ther Oncolytics Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Ther Oncolytics Year: 2022 Type: Article Affiliation country: United States